Kuros Biosciences Ltd.
Biologic tech for predictable spinal fusions, featuring the MagnetOs bone graft.
KURN | SW
Overview
Corporate Details
- ISIN(s):
- CH0325814116
- LEI:
- 5299006U5POB2AVTT709
- Country:
- Switzerland
- Address:
- Wagisstraße 25, 8952 Schlieren
- Website:
- https://kurosbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Kuros Biosciences is a medical technology company that discovers, develops, and delivers innovative biologic technologies for tissue repair and bone regeneration. The company's primary focus is on improving outcomes in spinal fusion surgery to address high rates of failed fusions. Its main product is MagnetOs, a bone graft featuring proprietary NeedleGrip™ surface technology, which is designed to grow bone even in soft tissues for more predictable fusions. Kuros Biosciences supports its products through 'Project Fusion,' a global research program that combines scientific, pre-clinical, and clinical studies. The company operates globally with a commercial and research footprint across three continents and more than 20 markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-16 02:00 |
Earnings Release
Kuros Biosciences increases the annual guidance for 2025, The company reports 7…
|
English | 12.7 KB | ||
| 2025-09-18 02:00 |
Legal Proceedings Report
Kuros statement on media inquiry concerning former Board member
|
English | 7.6 KB | ||
| 2025-09-04 02:00 |
Board/Management Information
Kuros Biosciences announces changes in the Board of Directors
|
English | 7.4 KB | ||
| 2025-08-14 02:00 |
Earnings Release
Kuros Biosciences Reports First Half of 2025 Results
|
English | 22.7 KB | ||
| 2025-03-11 01:00 |
Earnings Release
Kuros Biosciences grows sales to CHF 75.6 million for 2024
|
English | 19.2 KB | ||
| 2025-01-08 07:00 |
Legal Proceedings Report
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 13.7 KB | ||
| 2025-01-07 07:00 |
Regulatory News Service
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 13.7 KB | ||
| 2025-01-07 01:00 |
M&A Activity
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 11.8 KB | ||
| 2024-11-19 07:00 |
Board/Management Information
Kuros Biosciences Expands into Extremities Markets
|
English | 18.5 KB | ||
| 2024-11-19 01:00 |
Board/Management Information
Kuros Biosciences Expands into Extremities Markets
|
English | 16.1 KB | ||
| 2024-10-10 02:00 |
Earnings Release
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow brea…
|
English | 16.3 KB | ||
| 2024-08-08 07:00 |
Earnings Release
Kuros Biosciences Reports First Half of 2024 Results
|
English | 37.6 KB | ||
| 2024-08-08 02:00 |
Earnings Release
Kuros Biosciences Reports First Half of 2024 Results
|
English | 33.0 KB | ||
| 2024-06-25 07:00 |
Regulatory News Service
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 …
|
English | 17.2 KB | ||
| 2024-06-25 02:00 |
Regulatory News Service
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 …
|
English | 14.9 KB |
Automate Your Workflow. Get a real-time feed of all Kuros Biosciences Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kuros Biosciences Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kuros Biosciences Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-23 | N/A | Executive member | Sell | None | 1,264,800.00 CHF |
| 2025-04-17 | N/A | Executive member | Sell | None | 13,344.49 CHF |
| 2025-03-18 | N/A | Non-Executive member | Buy | None | 38,200.00 CHF |
| 2024-12-11 | N/A | Executive member | Sell | None | 4,702,500.00 CHF |
| 2024-11-15 | N/A | Non-Executive member | Buy | None | 925,210.00 CHF |
| 2024-11-14 | N/A | Non-Executive member | Sell | None | 592,000.00 CHF |
| 2024-11-12 | N/A | Executive member | Sell | None | 13,890.86 CHF |
| 2024-09-25 | N/A | Executive member | Sell | None | 8,226,000.00 CHF |
| 2024-09-25 | N/A | Non-Executive member | Sell | None | 3,656,000.00 CHF |
| 2024-09-24 | N/A | Non-Executive member | Buy | None | 223,720.00 CHF |
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
